Filings
Finds words inside filing documents. Searching Armata Pharmaceuticals, Inc.'s filings · 52 documents indexed.
10 documents · 51 matches
-
ARMP Armata Pharmaceuticals, Inc. 10-Q 2026-08-12
Item 1 · Note 2. Liquidity and Going Concern
that may result from the outcome of the uncertainty concerning the Company’s ability to continue as a going concern.7 matches in this document -
ARMP Armata Pharmaceuticals, Inc. 10-Q 2026-05-13
Item 1 · Note 2. Liquidity and Going Concern
that may result from the outcome of the uncertainty concerning the Company’s ability to continue as a going concern.7 matches in this document -
ARMP Armata Pharmaceuticals, Inc. 10-K 2026-03-25
Item 8 · Note 2. Liquidity and Going Concern
that may result from the outcome of the uncertainty concerning the Company’s ability to continue as a going concern.12 matches in this document -
ARMP Armata Pharmaceuticals, Inc. 10-Q 2025-11-12
Item 1 · Note 2. Liquidity and Going Concern
that may result from the outcome of the uncertainty concerning the Company’s ability to continue as a going concern.7 matches in this document -
ARMP Armata Pharmaceuticals, Inc. 10-Q 2025-08-12
Item 1 · Note 2. Liquidity and Going Concern
that may result from the outcome of the uncertainty concerning the Company’s ability to continue as a going concern.7 matches in this document -
ARMP Armata Pharmaceuticals, Inc. 10-Q 2025-05-14
Item 1 · Note 2. Liquidity and Going Concern
that may result from the outcome of the uncertainty concerning the Company’s ability to continue as a going concern.7 matches in this document -
ARMP Armata Pharmaceuticals, Inc. 8-K 2026-03-25
going concern. This announcement is made pursuant to the disclosure requirements of NYSE American Company Guide Sections 401(h) and 610(b).1 match in this document -
ARMP Armata Pharmaceuticals, Inc. 8-K 2025-10-22
going concern ; our ability to manufacture, or otherwise secure the manufacture of, sufficient amounts of our product candidates for our preclinical1 match in this document -
ARMP Armata Pharmaceuticals, Inc. 8-K 2025-09-11
going concern ; our ability to manufacture, or otherwise secure the manufacture of, sufficient amounts of our product candidates for our preclinical1 match in this document -
ARMP Armata Pharmaceuticals, Inc. 8-K 2025-05-19
going concern; our ability to manufacture, or otherwise secure the manufacture of, sufficient amounts of our product candidates for our preclinical1 match in this document
Page 1 of 1 · 10 documents